These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Potential of Translationally Controlled Tumor Protein-Derived Protein Transduction Domains as Antigen Carriers for Nasal Vaccine Delivery. Bae HD; Lee J; Jin XH; Lee K Mol Pharm; 2016 Sep; 13(9):3196-205. PubMed ID: 27454469 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Systemic and Mucosal Immune Responses Induced by a Nasal Powder Delivery System in Conjunction with an OVA Antigen in Cynomolgus Monkeys. Torikai Y; Sasaki Y; Sasaki K; Kyuno A; Haruta S; Tanimoto A J Pharm Sci; 2021 May; 110(5):2038-2046. PubMed ID: 33278410 [TBL] [Abstract][Full Text] [Related]
11. Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization. Matsunaga Y; Wakatsuki Y; Tabata Y; Kawasaki H; Usui T; Yoshida M; Itoh T; Habu S; Kita T Vaccine; 2000 Oct; 19(4-5):579-88. PubMed ID: 11027824 [TBL] [Abstract][Full Text] [Related]
12. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice. Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215 [TBL] [Abstract][Full Text] [Related]
13. Mannan-decorated thiolated Eudragit microspheres for targeting antigen presenting cells via nasal vaccination. Li HS; Singh B; Park TE; Hong ZS; Kang SK; Cho CS; Choi YJ Eur J Pharm Sci; 2015 Dec; 80():16-25. PubMed ID: 26415829 [TBL] [Abstract][Full Text] [Related]
14. Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice. Howe SE; Konjufca VH PLoS One; 2015; 10(2):e0118067. PubMed ID: 25710518 [TBL] [Abstract][Full Text] [Related]
16. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802 [TBL] [Abstract][Full Text] [Related]
17. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses. Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435 [TBL] [Abstract][Full Text] [Related]
18. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation. Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256 [TBL] [Abstract][Full Text] [Related]
19. Enhanced mucosal and systemic immune responses to a vaginal vaccine coadministered with RANTES-expressing plasmid DNA using in situ-gelling mucoadhesive delivery system. Oh YK; Park JS; Yoon H; Kim CK Vaccine; 2003 May; 21(17-18):1980-8. PubMed ID: 12706687 [TBL] [Abstract][Full Text] [Related]
20. Size effect on the antibody production induced by biodegradable microspheres containing antigen. Nakaoka R; Inoue Y; Tabata Y; Ikada Y Vaccine; 1996 Sep; 14(13):1251-6. PubMed ID: 8961514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]